GRTX
Ensign Peak Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-151,777
| Closed | -$474K | – | 1772 |
|
|
2023
Q2 | $474K | Hold |
151,777
| – | – | ﹤0.01% | 1646 |
|
|
2023
Q1 | $389K | Hold |
151,777
| – | – | ﹤0.01% | 1682 |
|
|
2022
Q4 | $226K | Hold |
151,777
| – | – | ﹤0.01% | 1739 |
|
|
2022
Q3 | $264K | Hold |
151,777
| – | – | ﹤0.01% | 1763 |
|
|
2022
Q2 | $197K | Buy |
151,777
+112,002
| +282% | +$145K | ﹤0.01% | 1796 |
|
|
2022
Q1 | $95K | Hold |
39,775
| – | – | ﹤0.01% | 2042 |
|
|
2021
Q4 | $153K | Buy |
+39,775
| New | +$153K | ﹤0.01% | 1979 |
|
|
2021
Q1 | – | Sell |
-7,128
| Closed | -$73K | – | 1894 |
|
|
2020
Q4 | $73K | Hold |
7,128
| – | – | ﹤0.01% | 1796 |
|
|
2020
Q3 | $64K | Sell |
7,128
-1,797
| -20% | -$16.1K | ﹤0.01% | 1720 |
|
|
2020
Q2 | $64K | Hold |
8,925
| – | – | ﹤0.01% | 1654 |
|
|
2020
Q1 | $85K | Sell |
8,925
-16,075
| -64% | -$153K | ﹤0.01% | 1584 |
|
|
2019
Q4 | $329K | Buy |
+25,000
| New | +$329K | ﹤0.01% | 1582 |
|